Target intelligence / Profile preview

RNA, U6 small nuclear 58, pseudogene (RNU6-58P)

Target
RNU6-58P
Molecular classification
Other (Pseudogene, Small nuclear RNA pseudogene)
01

Overview

RNU6-58P, also referred to as "RNA, U6 small nuclear 58, pseudogene," is a pseudogene of a small nuclear RNA (snRNA) originally involved in the splicing of pre-mRNA as part of the spliceosome machinery[7][2]. Functional U6 snRNA is an essential and highly conserved component of the spliceosomal complex, crucial for catalyzing intron removal from pre-messenger RNA[5]. However, because RNU6-58P is annotated as a pseudogene, it is generally regarded as a non-functional genomic copy and does not contribute to snRNP-mediated catalysis or splicing[7][2]. Pseudogenes typically arise from duplication or retrotransposition events and lack coding or regulatory potential required for normal cellular roles. No evidence supports its use as a therapeutic target or biomarker, and there are no drugs known to interact with this gene. Supporting details: - This gene is listed as a pseudogene, meaning it is not expected to produce a functional RNA product and is not involved directly in any known biological or disease pathways[7][2]. - No alternative molecular functions, drug interactions, or disease roles are attributed to it. - It has standard identifiers such as HGNC:42548, NCBI Gene: 100873766, and Ensembl: ENSG00000252952[7][2]. Note: This entry refers specifically to a pseudogene rather than the functional U6 small nuclear RNA. Functional U6 snRNA is important in RNA processing and splicing, but the pseudogene copy RNU6-58P does not share these activities[5][7].

Other names
RNU6-58RNA, U6 small nuclear 58, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 58, pseudogene (RNU6-58P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 58, pseudogene (RNU6-58P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call